Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 10319

1.

A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy.

Ahn Y, Kim Y, Chang K, Kim W, Rhee MY, Cha KS, Hyon MS, Shim CY, Lee SY, Kim DI, Kim SW, Lim SW, Han KR, Jo SH, Lee NH, Kwan J, Ahn T.

Medicine (Baltimore). 2018 Sep;97(37):e12329. doi: 10.1097/MD.0000000000012329.

2.

Trimethoprim-sulfamethoxazole-induced drug reaction with eosinophilia and systemic symptoms in a child with congenital renal disease.

Maarouf M, Wickenheiser M, Krase JM, Wolter S, Shi VY.

Pediatr Dermatol. 2018 Nov;35(6):e391-e392. doi: 10.1111/pde.13607. Epub 2018 Sep 6.

PMID:
30187970
3.

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH).

Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Gantenbein AR, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Paemeleire K, Sandset PM, Terwindt GM, Vetvik KG, Martelletti P; European Headache Federation (EHF), the European Society of Contraception and Reproductive Health (ESCRH).

J Headache Pain. 2018 Aug 31;19(1):76. doi: 10.1186/s10194-018-0896-5. Review.

4.

Mildes Asthma: «Budesonid plus Formoterol bei Bedarf» ist «Budesonid kontinuierlich eingenommen» nicht unterlegen.

Steurer J.

Praxis (Bern 1994). 2018 Aug;107(17-18):993-994. doi: 10.1024/1661-8157/a003052. German. No abstract available.

PMID:
30131030
5.

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.

Lo DK, Muhlebach MS, Smyth AR.

Cochrane Database Syst Rev. 2018 Jul 21;7:CD009650. doi: 10.1002/14651858.CD009650.pub4. Review.

PMID:
30030966
6.

Functional outcome after long-term low-dose trimethoprim/sulfamethoxazole in chronic rhinosinusitis with purulence: a prospective study.

de Bonnecaze G, Chaput B, Dupret-Bories A, Vergez S, Serrano E.

J Laryngol Otol. 2018 Jul;132(7):600-604. doi: 10.1017/S0022215118000452. Epub 2018 Jul 2.

PMID:
29961432
7.

Inhaled Corticosteroids and LABAs - Removal of the FDA's Boxed Warning.

Seymour SM, Lim R, Xia C, Andraca-Carrera E, Chowdhury BA.

N Engl J Med. 2018 Jun 28;378(26):2461-2463. doi: 10.1056/NEJMp1716858. No abstract available.

8.
9.

Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.

Anzueto AR, Kostikas K, Mezzi K, Shen S, Larbig M, Patalano F, Fogel R, Banerji D, Wedzicha JA.

Respir Res. 2018 Jun 20;19(1):121. doi: 10.1186/s12931-018-0830-z.

10.

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method.

Wambaugh MA, Brown JCS.

J Vis Exp. 2018 May 21;(135). doi: 10.3791/57241.

PMID:
29863672
11.

Efficacy of budesonide/formoterol and tiotropium combination for the treatment of Chinese patients with chronic obstructive pulmonary disease.

Feng JF, Ding GR, Xie YZ, Zhao D, Wang X.

Medicine (Baltimore). 2018 Jun;97(22):e10841. doi: 10.1097/MD.0000000000010841.

12.

Post-radiotherapy maintenance treatment with fluticasone propionate and salmeterol for lung cancer patients with grade III radiation pneumonitis: A case report.

Zhang P, Yan H, Wang S, Kai J, Pi G, Peng Y, Liu X, Sun J.

Medicine (Baltimore). 2018 May;97(21):e10681. doi: 10.1097/MD.0000000000010681.

13.

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD.

Kerwin EM, Siler TM, Arora S, Darken P, Rose E St, Reisner C.

Int J Chron Obstruct Pulmon Dis. 2018 May 8;13:1483-1494. doi: 10.2147/COPD.S164281. eCollection 2018.

14.

Amantadine in Chinese 'Cold and Flu' tablets: the cause of psychosis in a healthy man.

Turbayne AKB, Xu TT, Swaminathan A.

Intern Med J. 2018 May;48(5):601-602. doi: 10.1111/imj.13780. No abstract available.

PMID:
29722187
15.

Sulfamethoxazole - Trimethoprim represses csgD but maintains virulence genes at 30°C in a clinical Escherichia coli O157:H7 isolate.

Uhlich GA, Andreozzi E, Cottrell BJ, Reichenberger ER, Zhang X, Paoli GC.

PLoS One. 2018 May 2;13(5):e0196271. doi: 10.1371/journal.pone.0196271. eCollection 2018.

16.

A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers.

Alcaraz S, González-Saiz F, Trujols J, Vergara-Moragues E, Siñol N, Pérez de Los Cobos J; Buprenorphine Naloxone Survey Group.

Drug Alcohol Depend. 2018 Jun 1;187:278-284. doi: 10.1016/j.drugalcdep.2018.02.020. Epub 2018 Apr 11.

PMID:
29702336
17.

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study.

Vogelmeier CF, Chapman KR, Miravitlles M, Roche N, Vestbo J, Thach C, Banerji D, Fogel R, Patalano F, Olsson P, Kostikas K, Wedzicha JA.

Int J Chron Obstruct Pulmon Dis. 2018 Apr 10;13:1125-1134. doi: 10.2147/COPD.S160011. eCollection 2018.

18.

Dissolution of fine particle fraction from truncated Anderson cascade impactor with an enhancer cell.

Tay JYS, Liew CV, Heng PWS.

Int J Pharm. 2018 Jul 10;545(1-2):45-50. doi: 10.1016/j.ijpharm.2018.04.048. Epub 2018 Apr 22.

PMID:
29689370
19.

Once-daily triple therapy inhaler for COPD.

[No authors listed]

Drug Ther Bull. 2018 Apr;56(4):42-45. doi: 10.1136/dtb.2018.4.0611. Review.

PMID:
29650761
20.

Single-Pill Combinations in the Treatment of Hypertension in Adults: Beyond Convenience.

Imbeault B, Vallée M.

Can J Diabetes. 2018 Apr;42(2):205-208. doi: 10.1016/j.jcjd.2018.01.011. Epub 2018 Feb 5. Review.

PMID:
29602409

Supplemental Content

Loading ...
Support Center